{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:38:10Z","timestamp":1782351490998,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014426","name":"American Board of Psychiatry and Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005902","name":"Institute for Clinical and Translational Research, University of Wisconsin, Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.wneu.2020.11.107","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:49:34Z","timestamp":1606477774000},"page":"e63-e68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7093-7649","authenticated-orcid":false,"given":"Michael J.","family":"Armahizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Kruger","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunuk","family":"Seung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshman","family":"Kalasapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Sansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-9805","authenticated-orcid":false,"given":"Nicholas A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.11.107_bib1","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1523\/JNEUROSCI.21-17-06512.2001","article-title":"Cell swelling and a nonselective cation channel regulated by internal Ca 2 and ATP in native reactive astrocytes from adult rat brain","volume":"21","author":"Chen","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.wneu.2020.11.107_bib2","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1523\/JNEUROSCI.23-24-08568.2003","article-title":"Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain","volume":"23","author":"Chen","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.wneu.2020.11.107_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jcbfm.2011.159","article-title":"Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8","volume":"32","author":"Woo","year":"2012","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.wneu.2020.11.107_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm1390","article-title":"Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke","volume":"12","author":"Simard","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/STROKEAHA.113.003352","article-title":"Pilot study of intravenous glyburide in patients with a large ischemic stroke","volume":"45","author":"Sheth","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2020.11.107_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12028-014-9970-2","article-title":"Exploratory analysis of glyburide as a novel therapy for preventing brain swelling","volume":"21","author":"Sheth","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2020.11.107_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2020.11.107_bib8","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/STROKEAHA.107.482216","article-title":"Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke","volume":"38","author":"Kunte","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2020.11.107_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"issue":"Suppl 4","key":"10.1016\/j.wneu.2020.11.107_bib10","first-page":"2","article-title":"The Sur1-Trpm4 channel in spinal cord injury","author":"Simard","year":"2013","journal-title":"J\u00a0Spine"},{"key":"10.1016\/j.wneu.2020.11.107_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/14737175.2014.890891","article-title":"Potential of glyburide to reduce intracerebral edema in brain metastases","volume":"14","author":"Boggs","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.wneu.2020.11.107_bib12","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.3390\/ijms16034973","article-title":"Glibenclamide for the treatment of ischemic and hemorrhagic stroke","volume":"16","author":"Caffes","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2020.11.107_bib13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients","volume":"367","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib14","first-page":"134","article-title":"Glucose control after severe brain injury","volume":"11","author":"Mauro Oddo","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.wneu.2020.11.107_bib15","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00134-008-1045-4","article-title":"The management of plasma glucose in acute cerebral ischaemia and traumatic brain injury: more research needed","volume":"34","author":"Strong","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib16","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/CCM.0b013e31818f4026","article-title":"Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study","volume":"36","author":"Oddo","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.CCM.0000194536.89694.06","article-title":"Predisposing factors for hypoglycemia in the intensive care unit","volume":"34","author":"Vriesendorp","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00134-012-2681-2","article-title":"Risk factors for hypoglycemia in neurocritical care patients","volume":"38","author":"van Iersel","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib19","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1097\/01.CCM.0000282073.98414.4B","article-title":"Severe hypoglycemia in critically ill patients: risk factors and outcomes","volume":"35","author":"Krinsley","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib20","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.wneu.2020.11.107_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12028-013-9923-1","article-title":"Glibenclamide in cerebral ischemia and stroke","volume":"20","author":"Simard","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2020.11.107_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/j.1875-9114.1985.tb03404.x","article-title":"Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects","volume":"5","author":"Feldman","year":"1985","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.wneu.2020.11.107_bib23","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1186\/cc10322","article-title":"Mild hypoglycemia is independently associated with increased mortality in the critically ill","volume":"15","author":"Krinsley","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2020.11.107_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients","volume":"367","author":"Finfer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.11.107_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12028-010-9417-3","article-title":"Intensive versus conventional insulin therapy in critically ill neurologic patients","volume":"13","author":"Green","year":"2010","journal-title":"Neurocrit Care"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887502032492X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887502032492X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:56:39Z","timestamp":1761814599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187887502032492X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"alternative-id":["S187887502032492X"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.11.107","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.11.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}